Startseite Crystal structure of dimethanolato-k2O:O-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)dicopper(II), C34H32Cu2N12O2S2
Artikel Open Access

Crystal structure of dimethanolato-k2O:O-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)dicopper(II), C34H32Cu2N12O2S2

  • Xiang Fang , Jing Yang , Ya‐Wen Zhang , Xin‐Ya Lv , Xia Wang ORCID logo und Ning Song EMAIL logo
Veröffentlicht/Copyright: 4. März 2021

Abstract

C34H32Cu2N12O2S2, triclinic, P1 (no. 2), a = 7.7970(7) Å, b = 9.6110(9) Å, c = 12.7629(12) Å, α = 71.544(8)°, β = 79.322(8)°, γ = 83.734(8)°, Z = 1, V = 890.21(14) Å3, Rgt(F) = 0.0634, wRref(F2) = 0.1827, T = 291(2) K.

CCDC no.: 2062593

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Blue prism
Size:0.20 × 0.20 × 0.16 mm
Wavelength:Cu Kα radiation (1.54184 Å)
μ:2.99 mm−1
Diffractometer, scan mode:Xcalibur, ω
θmax, completeness:67.3°, 99%
N(hkl)measured, N(hkl)unique, Rint:6384, 6384
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 5176
N(param)refined:238
Programs:CrysAlisPRO [1], SHELX [2]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
Cu10.02074 (7)0.36055 (6)0.09413 (5)0.0420 (3)
S1−0.33898 (18)0.13713 (16)0.43127 (10)0.0637 (4)
O10.1441 (4)0.4783 (3)−0.0435 (3)0.0513 (8)
N10.1811 (4)0.1822 (3)0.1066 (3)0.0396 (7)
N20.2964 (4)−0.0393 (3)0.1824 (3)0.0395 (7)
N30.2365 (5)−0.2865 (4)0.2941 (3)0.0538 (9)
N40.2750 (7)−0.3960 (4)0.2455 (4)0.0747 (15)
N50.1417 (8)−0.4756 (5)0.2687 (5)0.0816 (17)
N6−0.1232 (5)0.2728 (4)0.2344 (3)0.0466 (8)
C10.3238 (6)−0.1359 (5)0.0163 (4)0.0502 (10)
H10.373452−0.2287240.0481590.060*
C20.2901 (7)−0.0905 (6)−0.0921 (4)0.0592 (12)
H20.319479−0.154387−0.1350010.071*
C30.2134 (6)0.0476 (7)−0.1394 (4)0.0589 (12)
H30.1916080.073225−0.2125170.071*
C40.1695 (6)0.1466 (5)−0.0804 (4)0.0496 (10)
H40.1172160.238442−0.1120950.060*
C50.2052 (5)0.1058 (4)0.0278 (3)0.0391 (8)
C60.2792 (5)−0.0345 (4)0.0745 (3)0.0382 (8)
C70.2379 (5)0.0932 (4)0.1965 (3)0.0393 (8)
C80.2481 (7)0.1353 (5)0.2972 (4)0.0515 (10)
H8A0.2210290.2389150.2825290.077*
H8B0.3640400.1120790.3153030.077*
H8C0.1657930.0823090.3588570.077*
C90.3555 (6)−0.1704 (5)0.2663 (4)0.0515 (10)
H9A0.471056−0.2040010.2374820.062*
H9B0.363219−0.1458290.3333110.062*
C100.0695 (6)−0.2955 (4)0.3497 (4)0.0468 (9)
C110.0090 (7)−0.4179 (5)0.3343 (4)0.0586 (12)
C12−0.1600 (8)−0.4617 (6)0.3808 (5)0.0689 (15)
H12−0.200801−0.5437710.3715840.083*
C13−0.2638 (7)−0.3800 (6)0.4405 (5)0.0625 (12)
H13−0.377695−0.4061420.4716130.075*
C14−0.2020 (7)−0.2578 (6)0.4556 (4)0.0574 (11)
H14−0.276216−0.2050410.4970940.069*
C15−0.0362 (6)−0.2127 (5)0.4115 (4)0.0505 (10)
H150.003875−0.1313030.4221990.061*
C16−0.2120 (5)0.2167 (4)0.3160 (3)0.0404 (9)
C170.3248 (6)0.4722 (6)−0.0825 (5)0.0689 (15)
H17A0.3837190.408008−0.0240430.103*
H17B0.3676190.568857−0.1043050.103*
H17C0.3465450.435490−0.1457660.103*

Source of material

All starting materials are commercially available without further purification. The educt 1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole (mbmb) was prepared according to the literature method [3]. The ligand mbmb (0.02 mmol, 0.0053 g) in methanol (6 mL) was added dropwise to a methanol solution (6 mL) of Cu(CH3COO)2 (0.02 mmol, 0.0040 g). Then an aqueous solution (2 mL) of KSCN (0.02 mmol, 0.0019 g) was added dropwise. The resulting solution was allowed to stand at room temperature. After three weeks blue crystals were obtained.

Experimental details

H atoms were generated geometrically and refined as riding atoms with C–H = 0.93 Å and the Uiso(H) = 1.2 times Ueq(C) for aromatic H atoms, with C–H = 0.97 Å and Uiso(H) = 1.2 times Ueq(C) for methylene H atoms, and with C–H = 0.96 Å and Uiso(H) = 1.5 times Ueq(C) for methyl H atoms.

Comment

In past the design and synthesis of coordination compounds have become a research hotspot in various fields, such as biochemistry [4], [ 5], food engineering [6] and medical [7]. N-containing heterocyclic ligands are widely used in the rational design and controlled synthesis of multifunctional complexes due to their abundant coordination and functional properties [8]. Benzotriazole and benzimidazole derivatives are excellent N-containing heterocyclic ligands, and they have been widely used as flexible ligands. Especially the incorporation of benzotriazole and benzimidazole can provide a new idea in the design of novel drug candidate molecules [9]. In addition, many Cu-containing complexes have extensive biological activities [10], [ 11].

The title compound contains a binuclear complex. As is shown in the Figure, each Cu(II) atom is four-coordinated by one N atom from a 1-[(2-methyl-1H-benzoimidazol-1-yl)methyl]-1H-benzotriazole ligand, one N atom from a thiocyanate ligand, two O atoms from two coordinated methanolato ligands (with the Cu1–N1 bond lengths of 1.990(3) Å, the Cu1–N6 bond lengths of 1.919(4) Å, the Cu1–O1 bond lengths of 1.909(3) Å and the Cu1–O1A bond lengths of 1.925(3) Å). The bond angles around Cu(II) ion range from 76.38(13) to 170.34(14)°. All geometric parameters are in the expected ranges [12], [ 13]. In addition, the benzotriazole rings in adjacent molecules are parallel, with an average interplanar distance of 3.89 Å, thus ππ interaction cannot be ruled out.


Corresponding author: Ning Song, College of Pharmacy, Henan University of Chinese Medicine, Zhengzhou450046, P. R. China, E-mail:

Funding source: Key Scientific and Research Projects of the Education Department of Henan Province

Award Identifier / Grant number: 21A430024

  1. Author contribution: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was financially supported by the Key Scientific and Research Projects of the Education Department of Henan Province (No. 21A430024).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Agilent Technologies. CrysAlisPRO Software System, (version 171.37.35); Agilent Technologies UK Ltd: Oxford, UK, 2014.Suche in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122; https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar

3. Moulton, B., Zaworotko, M.‐J. From molecules to crystal engineering: supramolecular isomerism and polymorphism in network solids. Chem. Rev. 2001, 101, 1629–1658; https://doi.org/10.1021/cr9900432.Suche in Google Scholar

4. Ou, Y. H., Du, R. K., Zhang, S. P., Ling, Y., Li, S., Zhao, C. J., Zhang, W. Z., Lei, Z. Synthesis, crystal structure and in vitro antifungal activity of two-dimensional silver(I)-voriconazole coordination complexes. J. Mol. Struct. 2020, 1215, 128229; https://doi.org/10.1016/j.molstruc.2020.128229.Suche in Google Scholar

5. Jin, R. Y., Wang, Y. Y., Guo, H., Long, X., Li, J. J., Yue, S. Y., Zhang, S., Zhang, G. H., Meng, Q. H., Wang, C., Yan, H., Tang, Y. P., Zhou, S. Design, synthesis, biological activity, crystal structure and theoretical calculations of novel 1,2,4-triazole derivatives. J. Mol. Struct. 2020, 1202, 127234; https://doi.org/10.1016/j.molstruc.2019.127234.Suche in Google Scholar

6. Qu, F., Wang, H., You, J. M. Dual lanthanide-probe based on coordination polymer networks for ratiometric detection of glyphosate in food samples. Food Chem. 2020, 323, 126815; https://doi.org/10.1016/j.foodchem.2020.126815.Suche in Google Scholar

7. Rehm, T., Rothemund, M., Bär, A., Dietel, T., Kempe, R., Kostrhunova, H., Brabec, V., Kasparkova, J., Schobert, R. N, N- Dialkylbenzimidazol-2-ylidene platinum complexes – effects of alkyl residues and ancillary cis-ligands on anticancer activity. Dalton Trans. 2020, 323, 17367–17381.10.1039/C8DT03360ASuche in Google Scholar PubMed

8. Lv, Z. C., Zhang, W. X., Zhao, H. Y. Two Cu(II)-based coordination polymers constructed from the pyridyl-carboxylate ligands: structural diversity and treatment activity on neonatal sepsis by reducing the over inflammatory response. Inorg. Nano‐Met. Chem. 2020, 50, 853–858; https://doi.org/10.1080/24701556.2020.1726956.Suche in Google Scholar

9. Wang, X., Ling, N., Li, Y. X., Zhang, S. L. Crystal structure of dichlorido-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)- 1H-benzo[d]triazole-κN)copper(II), C30H26CdCl2N10. Z. Kristallogr. NCS 2018, 233, 215–216; https://doi.org/10.1515/ncrs-2017-0211.Suche in Google Scholar

10. Wang, X. Y., Xiao, J., Ma, H. Q. Two new Cu(II)-based coordination polymers: inhibitory activity on prostate cancer by reducing EGF–R expression and HIPPO signaling pathway activation. J. Biomater. Sci. Polym. Ed. 2020, 31, 1741–1755; https://doi.org/10.1080/09205063.2020.1775057.Suche in Google Scholar

11. Dong, F. Q., Li, B. Y., Jin, X. W., Li, X. Z., Li, H. Y. New Cu(II)-bearing coordination polymer: crystal structure, molecular docking, and protective activity on coronary heart disease by reducing ROS production. J. Theor. Comput. Chem. 2019, 18, 150032; https://doi.org/10.1142/s0219633619500329.Suche in Google Scholar

12. Deng, Q.‐J., Chen, M., Chen, D.‐C., Long, H.‐Y., Chen, C.‐A. Tracking the dissolution-recrystallization structural transformation (DRST) of copper(II) complexes: a combined crystallographic, mass spectrometric and DFT study. Acta Crystallogr. 2020, C76, 655–662; https://doi.org/10.1107/s2053229620006701.Suche in Google Scholar

13. Ling, N., Wang, X., Zhang, Y. W., Zhao, T. T., Ruan, Y., Yang, J. Crystal structure of dimethanol-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)cadmium(II) C34H34CdN12O2S2. Z. Kristallogr. NCS 2019, 234, 881–882; https://doi.org/10.1515/ncrs-2019-0068.Suche in Google Scholar

Received: 2021-01-29
Accepted: 2021-02-11
Published Online: 2021-03-04
Published in Print: 2021-07-27

© 2021 Xiang Fang et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. Crystal structure of poly[(μ2-aqua-tetraaqua-(μ3-glutarato-κ4O,O′:O′:O′′)-(μ5-glutarato-κ6O:O,O′:O′:O′′:O′′′)distrontium(II)], C10H22O13Sr2
  4. The crystal structure of acetato-κ1O-{(2-(2-(2-aminophenoxy)ethoxy)phenyl)(4-oxo-4-phenylbut-2-en-2-yl)amido-κ2N,N′,O}copper(II), C26H26CuN2O5
  5. Crystal structure of dimethanolato-k2O:O-bis(1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κN)-bis(thiocyanato-κN)dicopper(II), C34H32Cu2N12O2S2
  6. Crystal structure of poly[diaqua-bis(μ2-3-(pyrimidin-5-yl)benzoato-κ2N:O)cobalt(II)] dihydrate, [Co(C11H11O2N2)2(H2O)2]
  7. Crystal structure of bis(3,3-dimethyl-1-phenylbut-1-en-2-yl)(trimethylsilyl)amido-k1N)zinc(II), Zn(C15H24NSi)2
  8. Crystal structure of catena-poly[(μ2-methanolato-κ2O:O)-(μ2-1-((2-methyl-1H-benzo[d]imidazol-1-yl)methyl)-1H-benzo[d][1,2,3]triazole-κ2N:N′)-(thiocyanato-κ1N)copper(II)] 0.25 hydrate, C17H16CuN6OS ⋅ 0.5H2O
  9. The crystal structure of 2-amino-5-nitroanilinium iodide monohydrate, C6H8IN3O2
  10. The crystal structure of 3-amino-5-carboxypyridin-1-ium perchlorate monohydrate, C6H9ClN2O7
  11. Crystal structure of 7-hydroxy-2,4-dimethoxy-9,10-dihydrophenanthrene from Arundina graminifolia, C16H16O3
  12. Crystal structure of 6,6′-((1E, 1′E)-(((1R, 2R)-1,2-diphenylethane-1,2-diyl) bis(azanylylidene))bis(methanylylidene))bis(2-ethylphenol), C32H32N2O2
  13. The crystal structure of 2-amino-5-carboxypyridin-1-ium iodide monohydrate, C6H9IN2O3
  14. The crystal structure of 2-(3,5-difluorophenyl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, C16H11BF2N2
  15. Crystal structure of bis{(2-pyridinyl)-1-phenyl-1-isopropylmethanolato-κ2N,O}nickel, C30H32N2NiO2
  16. Crystal structure of poly[(m3-3-carboxyadamantane-1-carboxylato-κ3O:O′:O″)-(phenanthroline-κ2N,N′)sodium(II)], C24H23N2NaO4
  17. Crystal structure of 2-phenylethynyl-1,3,6,8-tetramethylBOPHY (BOPHY = bis(difluoroboron)-1,2-bis((1H-pyrrol-2-yl)methylene)hydrazine), C22H20B2F4N4
  18. Crystal structure of 4-tert-butyl-2-N-(2-pyridylmethyl)aminophenol, C16H20N2O
  19. The crystal structure of (3Z,3′Z)-4,4′-((1,4-phenylenebis(methylene))bis(azanediyl))bis(pent-3-en-2-one), C18H24N2O2
  20. Crystal structure of (morpholine-1-carbodithioato-κ2-S,S′)bis(triphenylphosphine-κ-P)gold(I), C41H38AuNOP2S2
  21. Crystal structure of 1,4-bis(4-bromobenzyl)-4-(4-chlorophenyl)-1,4-dihydropyridine-3-carbonitrile, C26H19Br2ClN2
  22. The crystal structure of fac-tricarbonyl (N′-benzoyl-N,N-diphenylcarbamimidothioato-κ2S,O)-(pyrazole-κN)rhenium(I) — methanol (1/1) C26H23O4N4SRe
  23. The crystal structure of Ba2Mn(SeO3)2Cl2 containing 1[Mn(SeO3)2Cl2]4− chains
  24. Crystal structure of 3,3′,3″-((1E,1′E,1″E)-((nitrilotris(ethane-2,1-diyl))tris(azaneylylidene)) tris(methaneylylidene))tris(4-hydroxy-1-naphthaldehyde) monohydrate, C42H36N4O6·H2O
  25. The crystal structure of 4-(6-acetyl-5-methyl-4,7-dihydrotetrazolo[1,5-a]pyrimidin-7-yl)benzonitrile, C14H12N6O
  26. Crystal structure of benzo[d][1,3]dioxol-5-yl-2-(6-methoxynaphthalen-2-yl)propanoate, C21H18O5
  27. The crystal structure of ethyl 5-methyl-7-(4-(phenylthio)phenyl)-4,7-dihydrotetrazolo[1,5-a]pyrimidine-6-carboxylate, C20H19N5O2S
  28. Crystal structure of N′,N‴-((propane-2,2-diylbis(1H-pyrrole-5,2-diyl))bis(methaneylylidene))-di(isonicotinohydrazide)– water – dimethylformamide (1/4/2), C25H24N8O2·4H2O·2C3H7NO
  29. Synthesis and crystal structure of 4-(2,4-dinitrophenoxy)benzaldehyde, C13H8N2O6
  30. The crystal structure of 1-dodecylpyridin-1-ium bromide monohydrate, C17H32BrNO
  31. Crystal structure of (E)-amino(2-(4-(dimethylamino)benzylidene)hydrazineyl)methaniminium nitrate, C10H16N6O3
  32. Crystal structure of (E)-(2-((1H-pyrrol-2-yl)methylene)hydrazineyl)(amino)methaniminium nitrate monohydrate, C6H12N6O4
  33. The crystal structure of hexakis(1-propylimidazole-κ1N)copper(II) dichloride, C36H60Cl2CuN12
  34. The crystal structure of bis{(μ2-3,3-dimethyl-1-phenylbut-1-en-2-yl)((dimethylamino)dimethylsilyl)amido-κ3N,N′:N′}dilithium, C32H54Li2N4Si2
  35. The crystal structure of methyl 4-(1H-naphtho[1,8-de][1,3,2]diazaborinin-2(3H)-yl)benzoate, C18H15BN2O2
  36. Crystal structure of (E)-N-(1-((2-chlorothiazol-5-yl)methyl)pyridin-2(1H)-ylidene)-2,2,2-trifluoroacetamide, C11H7ClF3N3OS
  37. Crystal structure of N′, N‴-((propane-2,2-diylbis(1H-pyrrole-5,2-diyl))bis (methaneylylidene))di(picolinohydrazide) – water – methanol (1/1/1), C25H24N8O2·H2O·CH3OH
  38. Crystal structure of 3-(2-chloro-benzyl)-7-[4-(2-chloro-benzyl)-piperazin-1-yl]-5,6,8-trifluoro-3H-quinazolin-4-one, C26H21Cl2F3N4O
  39. Crystal structure of N1,N2-bis(2-fluorobenzyl)benzene-1,2-diamine,C20H18F2N2
  40. The crystal structure of 2-(benzo[d][1,3]dioxol-5-yl)-2,3-dihydro-1H-naphtho[1,8-de][1,3,2]diazaborinine, C17H13BN2O2
  41. The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methaneylylidene)) bis(2-bromo-4-nitrophenol) — dimethylsulfoxide (1/2), C14H8Br2N4O6⋅2(C2H6OS)
  42. Selective biocatalytic synthesis and crystal structure of (2R,6R)-hydroxyketaminium chloride, C13H17Cl2NO2
  43. Crystal structure of bis{tetraaqua-[μ3-1-(4-carboxylatophenyl)-5-methyl-1H-pyrazole-3-carboxylate-κ4N,O,O′,O″] [μ2-1-methyl-1H-pyrazole-3,5-dicarboxylate-κ3N,O:O]dicobalt(II)} dihydrate, C36H44Co4N8O26
  44. Crystal structure of diethyl-2,2′-naphthalene-2,3-diylbis(oxy)diacetate, C18H20O6
  45. Synthesis and crystal structure of poly[(μ3-2-(2-carboxylatophenyl)-1H-benzo[d]imidazole-5-carboxylato-κO,O′:O′;:O″, O″′)-(μ2-1-(4-(1Himidazol-1-yl)phenyl)-1H-imidazole-κ2N:N′)cadmium(II)], C27H18CdN6O4
  46. The crystal structure of catena-poly[diaqua-bis(μ2-2-((2-(2-phenylacetyl)hydrazineylidene)methyl)benzoato-κ2O:O')zinc(II)], C32H30N4O8Zn
  47. The crystal structure of 2-(3,4-dimethoxyphenyl)-2,3-dihydro-1H-naphtho [1,8-de][1,3,2]diazaborinine, C18H17BN2O2
  48. The crystal structure of hexakis(1-ethylimidazole-κ1N)nickel(II) dichloride – 1-ethylimidazole (1/2), C40H64Cl2NiN16
  49. Crystal structure of diaqua-bis(2,4-dinitrophenolato-κ2O,O′)copper(II) 1.5 hydrate, C12H13CuN4O13.5
  50. Crystal structure of N′,N‴-((1E,1′E)-((decane-1,10-diylbis(oxy))bis(2,1-phenylene)) bis(methaneylylidene))di(isonicotinohydrazide), C36H40N6O4
  51. The crystal structure of 2-[(R)-1-(naphthalen-1-yl)ethyl]-2,3,7,7a-tetrahydro-3a,6-epoxyisoindol-1(6H)-one, C19H20NO2
  52. Synthesis and crystal structure of (1E,2E)-3-(anthracen-9-yl)-1-(4-methoxyphenyl)prop-2-en-1-one oxime, C24H19NO2
  53. Synthesis and crystal structure of (2E,2′E)-3,3′-(1,3-phenylene)bis(1-(3-bromophenyl)prop-2-en-1-one), C24H16Br2O2
  54. The crystal structure of catena-poly[bis(µ2-1,2-bis((1H-imidazol-1-yl)methyl)benzene- κ2N:N′)-bis(nitrato-κO)copper(II)], C28H28N10O6Cu
  55. Synthesis and crystal structure of the novel chiral acetyl-3-thiophene-5-(9-anthryl)-2-pyrazoline, C23H18N2OS
  56. Crystal structure of (E)-3-(dimethylamino)-1-(thiophen-3-yl)prop-2-en-1-one, C9H11NOS
  57. Crystal structure of catena-poly[aqua-(4-iodopyridine-2,6-dicarboxylato-κ3N,O,O′)-(μ2-4-amino-4H-1,2,4-triazole-κ2N:N′) copper(II)], C9H8N5O5CuI
  58. Crystal structure of cyclopropane-1,2,3-triyltris(phenylmethanone), C24H18O3
  59. Crystal structure of bis(amino(thioureido)methaniminium) terephthalate, C12H18N8O4S2
  60. A three-dimensional Eu(III) framework in the crystal structure of dimethylaminium poly[dimethylformamide-κ1N)bis(μ4-terephthalato-κ4O:O′:O′′:O′′′)europium(III)] monohydrate, C21H25EuN2O10
  61. Crystal structure of 2-methoxyphenyl 2-(6-methoxynaphthalen-2-yl)propanoate, C21H20O4
  62. The crystal structure of Hexakis(diethylamido)dimolybdenum, Mo2(NEt2)6
Heruntergeladen am 22.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2021-0045/html
Button zum nach oben scrollen